v3.25.2
Warrants
3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Warrants and Rights Note Disclosure [Abstract]    
Warrants
6.
WARRANTS

 

Following is a summary of the warrant activity during the three months ended March 31, 2025 and 2024:

 

 

Number of Share Purchase Warrants

 

 

Weighted Average Exercise Price

 

Outstanding January 1, 2024

 

 

22,518,894

 

 

$

1.35

 

Issued

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Expired

 

 

(4,838,707

)

 

 

1.24

 

Outstanding March 31, 2024

 

 

17,680,187

 

 

$

1.21

 

 

 

 

 

 

 

 

Outstanding January 1, 2025

 

 

17,732,764

 

 

$

1.21

 

Issued

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

Expired

 

 

 

 

 

 

Outstanding March 31, 2025

 

 

17,732,764

 

 

$

1.21

 

 

As of March 31, 2025, the following share purchase warrants were outstanding and exercisable:

 

Outstanding

 

 

Exercise Price

 

Remaining life
(years)

 

 

Expiry Date

 

7,537,313

 

 

USD$1.50

 

 

1.08

 

 

April 29, 2026

 

10,195,451

 

 

USD$1.00

 

 

5.25

 

 

Jun 30, 2030

 

17,732,764

 

 

 

 

 

 

 

 

 

As of March 31, 2024, the following share purchase warrants were outstanding and exercisable:

 

Outstanding

 

 

Exercise Price

 

Remaining life
(years)

 

 

Expiry Date

 

7,537,313

 

 

USD$1.50

 

 

2.33

 

 

April 29, 2026

 

10,142,874

 

 

USD$1.00

 

 

6.50

 

 

June 30, 2030

 

17,680,187

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10. WARRANTS

On August 2, 2023, the Company issued 10,000,000 warrants with $1.00 exercise price in connection with the financing arrangement entered into with Secured Notes. The warrants allow the holder to purchase common stock at an exercise price equal to $1.00 per share at any time on or after their issuance date and on or prior to June 30, 2030. At time of issuance, the Company determined that the warrants had a fair value of $4.3 million and required classification as equity. On December 21, 2023, the total warrants increased by 142,874 warrants with an exercise price of US$1.00 per warrant in connection with Secured Notes amendment as described on footnote 11. The additional warrants had an estimated fair value of approximately $8 thousand and they were classified as equity in the Consolidated Balance Sheets as of December 31, 2023 and 2024.

The fair value of the warrants were measured using the Monte Carlo pricing model. Significant inputs into the model as of August 2, 2023 are as follows:

 

Monte Carlo Assumptions

 

August 2, 2023

 

 

 

 

 

Exercise price

 

$

1.00

 

Warrant expiration date

 

June 30, 2030

 

Stock price

 

$

0.85

 

Interest rate (annual) (1)

 

 

4.21

%

Volatility (annual) (2)

 

 

50.0

%

Remaining term (years)

 

 

6.91

 

Annualized dividend yield (3)

 

 

0

%